Innovative coating solutions created through science

Our technologies are rooted in over a decade of nanotechnology research at the University of Twente validated through 20+ awards, competitive EU and Dutch innovation grants, and active R&D partnerships with global medtech companies.

R&D

From lab towards (pre) clinical validation

LipoCoat works intensively with medical multinationals, academic institutions, and clinical partners to develop and validate new applications.

Become a partner

Sponsors and Research partners

Milestones

A track record of grant and investor validation

From an academic lipid-bilayer discovery to EU-backed clinical trials — a decade of grants, awards, and research partnerships that validated the science.

View our technology

Facilities

2015

Wins NanoNextNL "Dragon's Den" and NanoLabNL research voucher

2017

Secures €600K seed funding to develop the coating platform

2019

Named European Biotech Startup of the Year

2020

Secures €1.5M funding round (High Tech Fund Enschede, Innovation Fund Rabobank, informal investors); named Best Medical Device Coatings Company

2022

Partners with CEMMA Medical on a coated CVC catheter; wins Extreme Tech Challenge finalist spot

2025

Launches UROCOAT project with Health~Holland and University of Twente to develop an antibiotic-free catheter coating

Document

A coating inspired from the cell membrane: LipoCoat® in three applications

LipoCoat® is a 5 nm phospholipid coating that stops proteins and bacteria from adhering. What the new technology brochure shows for catheters, contact lenses and needles, and how it fits your production line.

Read

Document

News

Lipocoat celebrates its 10th anniversary and breaks ground on a new production lab in Enschede.

LipoCoat is building a 500-square-meter production lab across from the University of Twente and is marking its tenth anniversary. Constantijn van Oranje started construction.